TheraBionic P1 for Breast Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to learn if the TheraBionic P1 device given to patients with advanced or metastatic HR positive, HER2 negative breast cancer who have progressed on standard of care options can affect patients survival. The main questions it aims to answer are:
* will the TheraBionic P1 device affect progression free and overall survival in advanced or metastatic HR positive, HER2 negative breast cancer
* the long term safety and tolerability of the TheraBionic P1 device
* assessment of how the disease responded to the TheraBionic P1 device
Are You a Good Fit for This Trial?
This trial is for women aged 22 or older with advanced or metastatic hormone-positive, HER2-negative breast cancer who have already tried and not benefited from all standard treatments. Participants must be able to care for themselves, have at least a 3-month life expectancy, and agree to avoid pregnancy during the study.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- TheraBionic P1
Trial Overview
The study is testing the TheraBionic P1 device in women with advanced HR positive, HER2 negative breast cancer that has stopped responding to other treatments. The main goals are to see if it helps patients live longer and how safe it is over time.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Self administered Amplitude-modulated electromagnetic fields three times daily
Find a Clinic Near You
Who Is Running the Clinical Trial?
Barbara Ann Karmanos Cancer Institute
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.